TROG Cancer Research
Members Login   CQMS Login  

Upcoming lung trials

TD 17.01 (DESSERT) - This study aims to show that use of a Decision Support System (DSS) will increase the proportion of patients receiving radiotherapy tailored to their individual prognostic profile, improve patient satisfaction with the decision making process and reduce decisional regret after treatment

Primary sponsor: TROG


TD 13.03 (SABR-OS) - This trial will investigate if Stereotactic Ablative Body Radiotherapy (SABR) is more effective than surgery for early stage Non-Small Cell Lung Cancer (NSCLC) in patients considered at high risk of surgical resection.

Primary sponsor: TROG


TROG 16.03 (CORE) - this study aims to show that the addition of SBRT (stereotactic body radiotherapy) to standard of care improves progression free survival for patients with extra-cranial oligiometastatic disease that has spread from their lung, breast and/or prostate cancer

Primary sponsor: Institute of Cancer Research (ICR)
Collaborating groups: TROG


 

We are thankful to our 14,000 patients who have participated in our research. Please continue the generous support.